AMSTERDAM and LAS VEGAS, Oct. 14,
2016 /PRNewswire/ -- Royal Philips (NYSE: PHG AEX:
PHIA) today announced at The American College of Emergency
Physicians' (ACEP) annual meeting that it has received 510(k)
clearance from the U.S. Food and Drug Administration (FDA) to
market its innovative S4-1 cardiac transducer for Lumify, its
smart-device diagnostic ultrasound solution. The pocket-sized and
lightweight S4-1 transducer now offers advanced sensitivity and
exceptional high-resolution 2D image quality, along with new exam
pre-sets, allowing clinicians to quickly triage and assess their
patients like never before.
Introduced in 2015, Lumify, the Philips smart device powered
ultrasound solution, helps healthcare professionals make fast,
informed decisions. Now Lumify is the first Philips
ultrasound device for ambulatory use, and with the S4-1 transducer,
its clinical applications are expanded to include a full offering
of in-demand cardiac, abdominal including lung, OB/GYN, and FAST
exam pre-sets. With Lumify's full suite of point-of-care
transducers, physicians in emergency care situations can take
advantage of every crucial moment without the time and mobility
restrictions of locating an ultrasound cart, which is often in use
and/or in another department.
"Lumify is a game-changing innovation," said Dr. John Bailitz, emergency ultrasound
physician and leader with ACEP and the Social Media and Critical
Care (SMACC) organization. "The affordability, flexibility and
versatility of Lumify make it appealing to those working in
emergency settings, and now with the S4-1 cardiac probe and FAST
exam pre-sets, we can conduct critical exams at the point-of-care,
resulting in more efficient triage of patients."
The Lumify app and all three transducers (L12-4, C5-2, and S4-1)
completed rigorous environmental and durability testing to ensure
reliability for emergency, critical care, and ambulance use. The
S4-1 transducer and cable weighs 152 grams and is smaller than a
smartphone, adding to its versatility and mobility. Beyond
integrating with everyday technology, such as off-the-shelf,
compatible smart devices, Lumify also uses cloud-enabled technology
to connect with PACS, shared networks and system directories.
Additionally, data will be accessible on the Philips HealthSuite
Digital Platform, an open and secure, cloud-based IT
infrastructure, allowing clinicians and health systems access to
powerful data and analytics to help improve patient care.
"Our vision for smart-device ultrasounds is focused on putting
high-quality devices in the hands of more professionals to serve
more patients in more locations," said Randy Hamlin, VP and Point-of-Care Business
Leader for Philips Ultrasound. "With the S4-1 transducer and
clinical pre-sets, Lumify is further extending the reach of
ultrasound by delivering exceptional image quality, now for routine
cardiac exams, and creating better connections between clinicians
and their patients."
In addition to the innovative subscription pricing model, Lumify
is also now available through a one-time purchase
transaction. For more information on Lumify and the full
suite of Philips advanced ultrasound solutions, visit
www.lumify.philips.com. Lumify will also be showcased at the RSNA
2016 annual meeting in Chicago,
Ill., Nov. 27 – Dec. 1. Follow @PhilipsLiveFrom and visit
www.philips.com/rsna for updates on Philips integrated technology,
software solutions and services driving first time right diagnosis
and treatment in radiology.
About Royal
Philips
Royal Philips
(NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and enabling better outcomes
across the health continuum from healthy living and prevention, to
diagnosis, treatment and home care. Philips leverages advanced
technology and deep clinical and consumer insights to deliver
integrated solutions. The company is a leader in diagnostic
imaging, image-guided therapy, patient monitoring and health
informatics, as well as in consumer health and home care.
Headquartered in the Netherlands,
Philips' health technology portfolio generated 2015 sales of
EUR 16.8 billion and employs
approximately 69,000 employees with sales and services in more than
100 countries. News about Philips can be found
at www.philips.com/newscenter.
Photo -
http://photos.prnewswire.com/prnh/20161013/428688
Photo - http://photos.prnewswire.com/prnh/20161013/428687
Logo - http://photos.prnewswire.com/prnh/20150611/222617LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/philips-receives-fda-510k-clearance-for-lumifys-s4-1-transducer-bringing-new-capabilities-including-cardiac-imaging-to-this-smart-device-ultrasound-300345079.html
SOURCE Royal Philips